Levamlodipine Besylate/Valsartan (Sunshine Novo)

Product Name :
Levamlodipine Besylate/Valsartan (Sunshine Novo)

Search keywords :
Levamlodipine (besylate)

drugId :
null

Target Vo:
Angiotensin II Receptor Type 1

Target Vo Short Name :
AT1

Moa_Name:
Voltage-gated calcium channel blockers

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Beijing Sunshine Novo Pharmaceutical Research Co Ltd

Active Company_Name :
Beijing Baiao Pharmaceuticals Co Ltd

Active Indication_Name:
Hypertension

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
KDM1A (YP7017) Mouse mAb Description
MUC16 Antibody (YA890) Protocol
Pyruvate Dehydrogenase E2 Antibody: Pyruvate Dehydrogenase E2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to Pyruvate Dehydrogenase E2. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts